NIOSH skin notation (SK) profile; acrylamide [CAS No. 79-06-1]
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Add terms to the query box

Query box

Help
Clear All
Filetype[PDF-12.19 MB]


Select the Download button to view the document
This document is over 5mb in size and cannot be previewed

Details:

  • Alternative Title:
    Acrylamide [CAS No. 79-06-1] ; NIOSH skin notation profile : acrylamide [CAS No. 79-06-1] ;
  • Description:
    "This Skin Notation Profile presents (1) a brief summary of technical data associated with skin contact with acrylamide and (2) the rationale behind the hazard-specific skin notation (SK) assignment for acrylamide. The SK assignment is based on the scientific rationale and logic outlined in the Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2009]. The summarized information and health hazard assessment are limited to an evaluation of the potential health effects of dermal exposure to acrylamide. A literature search was conducted through July 2010 to identify information on acrylamide, including but not limited to data relating to its toxicokinetics, acute toxicity, repeated-dose systemic toxicity, carcinogenicity, biological system/function-specific effects (including reproductive and developmental effects and immunotoxicity), irritation, and sensitization. Information was considered from studies of humans, animals, or appropriate modeling systems that are relevant to assessing the effects of dermal exposure to acrylamide. Acrylamide is potentially capable of causing numerous adverse health effects following skin contact. A critical review of available data has resulted in the following SK assignment for acrylamide: SK: SYS-DIR (IRR)-SEN. Table 1 provides an overview of the critical effects and data used to develop the SK assignment for acrylamide." - NIOSHTIC-2
  • Content Notes:
    "This document was developed by the Education and Information Division, Paul Schulte, Ph.D., Director. G. Scott Dotson, Ph.D. was the project officer for this document. Other NIOSH personnel, in particular Fredrick H. Frasch, Ph.D., Charles L. Geraci, Ph.D., Thomas J. Lentz, Ph.D., Richard Niemeier, Ph.D., and Angie Shepherd, contributed to its development by providing technical reviews and comments. The basis for this document was a report contracted by NIOSH and prepared by Bernard Gadagbui, Ph.D., and Andrew Maier, Ph.D. (Toxicology Excellence for Risk Assessment [TERA])." -- p. ix Includes bibliographical references (p. 8-10).
  • Main Document Checksum:
  • File Type:

Supporting Files

  • No Additional Files

More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov